Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3)

Molecular and Cellular Proteomics

Volumn 14, Issue 5, 2015, Pages 1373-1384

  Plomp, Rosina ^a   Dekkers, Gillian ^c   Rombouts, Yoann ^a,b   Visser, Remco ^c   Koeleman, Carolien A M ^a   Kammeijer, Guinevere S M ^a   Jansen, Bas C ^a   Rispens, Theo ^d   Hensbergen, Paul J ^a   Vidarsson, Gestur ^c   Wuhrer, Manfred ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Experimental Immunohematology ^*  (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G3; PROTEINASE K; TRYPSIN; IMMUNOGLOBULIN G; PEPTIDE; RECOMBINANT PROTEIN; THREONINE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ELECTRON TRANSPORT; ELECTROSPRAY; FEMALE; GLYCOSYLATION; HINGE REGION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; CARBOHYDRATE ANALYSIS; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MUTATION;

ADULT; AMINO ACID SEQUENCE; CARBOHYDRATE SEQUENCE; FEMALE; GENE EXPRESSION; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEOLYSIS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; THREONINE; TRYPSIN;

EID: 84929657763     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.047381     Document Type: Article

References (52)

1. Stoop, J. W., Zegers, B. J., Sander, P. C., and Ballieux, R. E. (1969) Serum immunoglobulin levels in healthy children and adults. Clin. Experiment. Immunol. 4, 101-112
2. Morell, A., Terry, W. D., and Waldmann, T. A. (1970) Metabolic properties of IgG subclasses in man. J. Clin. Invest. 49, 673-680
3. Vidarsson, G., Dekkers, G., and Rispens, T. (2014) IgG subclasses and allotypes: From structure to effector functions. Frontiers Immunol. 5, 520
4. Roux, K. H., Strelets, L., and Michaelsen, T. E. (1997) Flexibility of human IgG subclasses. J. Immunol. 159, 3372-3382
5. Dangl, J. L., Wensel, T. G., Morrison, S. L., Stryer, L., Herzenberg, L. A., and Oi, V. T. (1988) Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 7, 1989-1994
6. Scharf, O., Golding, H., King, L. R., Eller, N., Frazier, D., Golding, B., and Scott, D. E. (2001) Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J. Virol. 75, 6558-6565
7. Cavacini, L. A., Emes, C. L., Power, J., Desharnais, F. D., Duval, M., Montefiori, D., and Posner, M. R. (1995) Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. J. Immunol. 155, 3638-3644
8. Redpath, S., Michaelsen, T., Sandlie, I., and Clark, M. R. (1998) Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52. Immunology 93, 595-600
9. Norderhaug, L., Brekke, O. H., Bremnes, B., Sandin, R., Aase, A., Michaelsen, T. E., and Sandlie, I. (1991) Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge. European J. Immunol. 21, 2379-2384
10. Natsume, A., In, M., Takamura, H., Nakagawa, T., Shimizu, Y., Kitajima, K., Wakitani, M., Ohta, S., Satoh, M., Shitara, K., and Niwa, R. (2008) Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities. Cancer Res. 68, 3863-3872
11. Hogarth, P. M., and Pietersz, G. A. (2012) Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nature Rev. Drug Discovery 11, 311-331
12. Canfield, S. M., and Morrison, S. L. (1991) The binding-affinity of human-IgG for its high-affinity Fc receptor is determined by multiple amino-acids in the Ch2 domain and is modulated by the hinge region. J. Exper. Med. 173, 1483-1491
13. Stapleton, N. M., Andersen, J. T., Stemerding, A. M., Bjarnarson, S. P., Verheul, R. C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., Jonsdottir, I., van der Schoot, C. E., and Vidarsson, G. (2011) Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nature Commun. 2, 599
14. Einarsdottir, H., Ji, Y., Visser, R., Mo, C., Luo, G., Scherjon, S., van der Schoot, C. E., and Vidarsson, G. (2014) H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: Implications for alloantibody-mediated diseases of the newborn. Transfusion 54, 665-671
15. Dard, P., Lefranc, M. P., Osipova, L., and Sanchez-Mazas, A. (2001) DNA sequence variability of IGHG3 alleles associated to the main G3m haplotypes in human populations. Eur. J. Human Genetics 9, 765-772
16. Jefferis, R., and Lefranc, M. P. (2009) Human immunoglobulin allotypes: Possible implications for immunogenicity. mAbs 1, 332-338
17. Dard, P., Huck, S., Frippiat, J. P., Lefranc, G., Langaney, A., Lefranc, M. P., and Sanchez-Mazas, A. (1997) The IGHG3 gene shows a structural polymorphism characterized by different hinge lengths: Sequence of a new 2-exon hinge gene. Human Genetics 99, 138-141
18. Anthony, R. M., and Nimmerjahn, F. (2011) The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo. Curr. Op. Organ Transplant. 16, 7-14
19. Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H., and Presta, L. G. (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biolog. Chem. 277, 26733-26740
20. Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C. A., Visser, R., Einarsdottir, H. K., Porcelijn, L., Jackson, D., Kumpel, B., Deelder, A. M., Blank, D., Skogen, B., Killie, M. K., Michaelsen, T. E., de Haas, M., Rispens, T., van der Schoot, C. E., Wuhrer, M., and Vidarsson, G. (2014) A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123, 471-480
21. Kaneko, Y., Nimmerjahn, F., and Ravetch, J. V. (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670-673
22. Karsten, C. M., Pandey, M. K., Figge, J., Kilchenstein, R., Taylor, P. R., Rosas, M., McDonald, J. U., Orr, S. J., Berger, M., Petzold, D., Blanchard, V., Winkler, A., Hess, C., Reid, D. M., Majoul, I. V., Strait, R. T., Harris, N. L., Köhl, G., Wex, E., Ludwig, R., Zillikens, D., Nimmerjahn, F., Finkelman, F. D., Brown, G. D., Ehlers, M., and Köhl, J. (2012) Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc[gamma[RIIB and dectin-1. Nature Med. 18, 1401-1406
23. Kim, H., Yamaguchi, Y., Masuda, K., Matsunaga, C., Yamamoto, K., Irimura, T., Takahashi, N., Kato, K., and Arata, Y. (1994) O-glycosylation in hinge region of mouse immunoglobulin G2b. J. Biolog. Chem. 269, 12345-12350
24. Mattu, T. S., Pleass, R. J., Willis, A. C., Kilian, M., Wormald, M. R., Lellouch, A. C., Rudd, P. M., Woof, J. M., and Dwek, R. A. (1998) The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J. Biolog. Chem. 273, 2260-2272
25. Takahashi, N., Tetaert, D., Debuire, B., Lin, L. C., and Putnam, F. W. (1982) Complete amino acid sequence of the delta heavy chain of human immunoglobulin D. Proc. Natl. Acad. Sci. U.S.A. 79, 2850-2854
26. Takayasu, T., Suzuki, S., Kametani, F., Takahashi, N., Shinoda, T., Okuyama, T., and Munekata, E. (1982) Amino acid sequence of galactosamine-containing glycopeptides in the hinge region of a human immunoglobulin D. Biochem. Biophys. Res. Commun.105, 1066-1071
27. Reinholdt, J., Tomana, M., Mortensen, S. B., and Kilian, M. (1990) Molecular aspects of immunoglobulin A1 degradation by oral streptococci. Infection Immun. 58, 1186-1194
28. Kruijsen, D., Einarsdottir, H. K., Schijf, M. A., Coenjaerts, F. E., van der Schoot, E. C., Vidarsson, G., and van Bleek, G. M. (2013) Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice. J. Virol. 87, 7550-7557
29. Vink, T., Oudshoorn-Dickmann, M., Roza, M., Reitsma, J. J., and de Jong, R. N. (2014) A simple, robust and highly efficient transient expression system for producing antibodies. Methods 65, 5-10
30. Rispens, T., Davies, A. M., Ooijevaar-de Heer, P., Absalah, S., Bende, O., Sutton, B. J., Vidarsson, G., and Aalberse, R. C. (2014) Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic Fab arm exchange. J. Biolog. Chem. 289, 6098-6109
31. Selman, M. H., Derks, R. J., Bondt, A., Palmblad, M., Schoenmaker, B., Koeleman, C. A., van de Geijn, F. E., Dolhain, R. J., Deelder, A. M., and Wuhrer, M. (2012) Fc specific IgG glycosylation profiling by robust nanoreverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J. Proteomics 75, 1318-1329
32. Tarp, M. A., and Clausen, H. (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim. Biophys. Acta 1780, 546-563
33. Domon, B., and Costello, C. E. (1988) A systematic nomenclature for carbohydrate fragmentations in Fab-Ms Ms spectra of glycoconjugates. Glycoconjugate J. 5, 397-409
34. Edelman, G. M., Cunningham, B. A., Gall, W. E., Gottlieb, P. D., Rutishauser, U., and Waxdal, M. J. (1969) The covalent structure of an entire gamma G immunoglobulin molecule. Proc. Natl. Acad. Sci. U.S.A. 63, 78-85
35. Stavenhagen, K., Hinneburg, H., Thaysen-Andersen, M., Hartmann, L., Varón Silva, D., Fuchser, J., Kaspar, S., Rapp, E., Seeberger, P. H., and Kolarich, D. (2013) Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J. Mass Spec. 48, 627-639
36. Baković, M. P., Selman, M. H., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A. M., Lauc, G., and Wuhrer, M. (2013) High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J. Proteome Res. 12, 821-831
37. Croset, A., Delafosse, L., Gaudry, J. P., Arod, C., Glez, L., Losberger, C., Begue, D., Krstanovic, A., Robert, F., Vilbois, F., Chevalet, L., and Antonsson, B. (2012) Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells. J. Biotech. 161, 336-348
38. Chen, F. T., Dobashi, T. S., and Evangelista, R. A. (1998) Quantitative analysis of sugar constituents of glycoproteins by capillary electrophoresis. Glycobiology 8, 1045-1052
39. Pedroso, M. M., Pesquero, N. C., Thomaz, S. M., Roque-Barreira, M. C., Faria, R. C., and Bueno, P. R. (2012) Jacalin interaction with human immunoglobulin A1 and bovine immunoglobulin G1: Affinity constant determined by piezoelectric biosensoring. Glycobiology 22, 326-331
40. Hortin, G. L., and Trimpe, B. L. (1990) Lectin affinity chromatography of proteins bearing O-linked oligosaccharides: application of jacalin-aga-rose. Anal. Biochem. 188, 271-277
41. Wilson, I. B., Gavel, Y., and von Heijne, G. (1991) Amino acid distributions around O-linked glycosylation sites. Biochem. J. 275, 529-534
42. Johnson, P. M., Michaelsen, T. E., and Scopes, P. M. (1975) Conformation of the hinge region and various fragments of human IgG3. Scandinavian J. Immunol. 4, 113-119
43. Julenius, K., Mølgaard, A., Gupta, R., and Brunak, S. (2005) Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15, 153-164
44. Ahmed, A. A., Giddens, J., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L. X., and Bjorkman, P. J. (2014) Structural characterization of anti-inflammatory immunoglobulin g fc proteins. J. Molecular Biol. 426, 3166-3179
45. Brezski, R. J., and Jordan, R. E. (2010) Cleavage of IgGs by proteases associated with invasive diseases: An evasion tactic against host immunity? mAbs 2, 212-220
46. Brezski, R. J., Vafa, O., Petrone, D., Tam, S. H., Powers, G., Ryan, M. H., Luongo, J. L., Oberholtzer, A., Knight, D. M., and Jordan, R. E. (2009) Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge. Proc. Natl. Acad. Sci. U.S.A. 106, 17864-17869
47. Baici, A., Knöpfel, M., Fehr, K., Skvaril, F., and Böni, A. (1980) Kinetics of the different susceptibilities of the four human immunoglobulin G subclasses to proteolysis by human lysosomal elastase. Scandinavian J. Immunol. 12, 41-50
48. Virella, G., and Parkhouse, R. M. (1971) Papain sensitivity of heavy chain sub-classes in normal human IgG and localizaton of antigenic determinants for the sub-classes. Immunochemistry 8, 243-250
49. Turner, M. W., Bennich, H. H., and Natvig, J. B. (1970) Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time. Clin. Experiment. Immunol. 7, 603-625
50. Tomana, M., Novak, J., Julian, B. A., Matousovic, K., Konecny, K., and Mestecky, J. (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73-81
51. Lehoux, S., Mi, R., Aryal, R. P., Wang, Y., Schjoldager, K. T., Clausen, H., van Die, I., Han, Y., Chapman, A. B., Cummings, R. D., and Ju, T. (2014) Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin a (IgA) nephropathy and healthy individuals. Mol. Cell. Proteomics 13, 3097-3113
52. Imai, H., Hamai, K., Komatsuda, A., Ohtani, H., and Miura, A. B. (1997) IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 51, 270-276